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ibstract A family of mammalian homologues of the Caeno- 
r-habditis elegans cell death protein Ced3 has been recently dis- 
covered. These mammalian proteins encode novel cysteine pro- 
teases with homology to the interleukin-l/3 converting enzyme 
(ICE). Although several studies support a role for one or more 
ctf these proteases in mediating apoptosis, their mechanism of 
action is far from understood. The presence of multiple mammal- 
ian ICE-like proteases, with apparently similar apoptotic func- 
tion indicates that, despite its conservation during evolution, the 
cell death pathway is much more complex in mammals than in 
the worm. In addition to ICE-like proteases, several other pro- 
teases of different cleavage specificities have been implicated in 
apoptosis. There is now a growing body of evidence suggesting 
that apoptosis involves the activation of a cascade of proteases. 
This article summarises the presently available evidence and dis- 
cusses how multiple proteases might be required in the effector 
phase of cell death. 
i:ey words: Apoptosis; Cysteine proteases; Interleukin-lp 
c onverting enzyme; Nedd2/Ich-I ; prICEICPP32TYamal 
;ipopain; TXIICE,,,II/Ich-2; ICEJII; Mch2 
1. Introduction 
More than two decades ago Kerr et al. [l] described the 
distinctive ultrastructure features of physiological cell death 
( tpoptosis). Apoptosis is now known to play key roles in devel- 
( pment and homeostasis, and understanding the molecular 
mechanisms of cellular suicide has been an area of intense 
r.:search for the past few years. Using classical genetic methods, 
s :veral genes that play a role in programmed cell death of the 
V, orm Caenorhahditis eleguns were identified [2]. Two of these, 
c Ed-3 and ted-4 were shown to be essential for cell death to 
(‘:cur, while ted-9 negatively regulates the function of ted-3 and 
c .rd-4 (reviewed in [3]). The Ced-9 protein is homologous to the 
nrammalian Bcl-2 family of apoptosis regulatory proteins [3]. 
Although no mammalian homologues of Ced-4 have been dis- 
c jvered, the ted-3 gene product is homologous to a growing list 
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of mammalian proteins similar to interleukin-l/3-converting en- 
zyme (ICE), a cysteine protease required for the processing of 
pro-IL-lp [4-71. Currently, the ICE family of cysteine proteases 
includes Nedd2/Ich-1 [8,9], prICE/CPP32/ydma/apopain [lo- 
131, TX/lch-2/ICE,,,II [14-161 , ICE,,,111 [16] and Mch2 [17]. 
Apoptosis is an event that requires dismantling of the cellular 
architecture, therefore the involvement of proteases is not sur- 
prising. Even before the discovery of ted-3 and its mammalian 
counterparts, it had been shown that a number of cellular 
proteins including poly(ADP-ribose) polymerase (PARP), 
lamin B, topoisomerases, protein kinase C pl, cytosolic phos- 
pholipase A, and histone Hl are degraded during apoptosis 
[18]. More recently, the product of adematous polyposis coli 
gene (APC) [19], terminin antigen [20], Ul-70kD [21], fodrin 
[22] and j?-actin [23] have been shown to be cleaved in cells 
undergoing apoptosis. Cytotoxic T-cells produce a series of 
serine proteases (granzymes) which are necessary for target cell 
killing by the induction of apoptosis (reviewed in [24]). Protease 
inhibitors of different specificities including serine and cysteine 
protease inhibitors, have been shown to inhibit apoptosis which 
illustrates that apoptosis may require the activation of several 
classes of proteases [18, 25-331. 
The genetic regulation of apoptosis has been a topic of sev- 
eral recent reviews and the possible role of ICE-like proteases 
in apoptosis has also been discussed to some extent [34-371. The 
aim of this article is examine the recent functional data on the 
ICE-family of proteins and to speculate how these members 
may act in alliance with non-ICE-like proteases in the execution 
of the apoptotic pathway. 
2. Multiple mammalian homologues of Ced3 
Among the six mammalian homologues of Ced-3 currently 
known, ICE is the best studied as it was first identified for its 
role in the processing of pro-interleukin-la (pIL-I/?) to active 
IL- lb. The crystal structure showed that the active form of ICE 
is a (p20+p10)2 tetramer consisting of two heterodimers of the 
p20 and pl0 subunits [38,39]. Earlier suggestions as to a role 
for ICE in apoptosis came from studies showing that overex- 
pression of ICE results in cell death and that ICE inhibitors 
such as cowpox virus CrmA [40] can suppress apoptosis in- 
duced by various stimuli [7,41-44]. Mice lacking ICE develop 
normally, but have defective IL-I/3 processing and Fas-medi- 
ated apoptosis [45,46]. Significantly though, ICE (-/-) mice do 
not show a Ipr phenotype, characteristic of mice carrying a 
mutation in the& gene. Clearly, ICE alone is not sufficient to 
mediate apoptosis. 
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Fig. 1. Known, possible and unknown relationships between various proteases implicated in apoptosis. Proteases in black boxes represent ICE-like 
proteases. Granzyme A (GraA) and granzyme B (GraB) are cytotoxic T-cell specific proteases. Established (continuous lines) and possible (dashed 
lines) interactions between various proteases and between proteases and their substrates are shown by arrows. PARP has been placed in the centre 
because it can be cleaved by several members of the ICE family. The cleavage of PARP by ICE, TX and Nedd2 occurs at relatively high concentrations 
[48] and this is shown by light-coloured arrows, Since ICE is not expressed in all cell types and ICE mutant mice show normal apoptosis, the function 
of ICE in cells lacking ICE may be carried out by proteases most similar to ICE, i.e. ICE,,11 (TX) and ICEJII. This would imply that one or both 
of these proteases process pro_Yama/CPP32, pro-Mch2 and pro-Nedd2 (these possible interactions are not shown in the figure). 
Overexpression of all ICE-like proteases induces apoptosis 
in transfected cells. Conversely, the expression of either anti- 
sense Nedd2 or a smaller form of Nedd2 protein (NeddZslIch- 
1s) partially inhibits cell death [9,47]. prICE (protease resem- 
bling ICE) was originally identified as a protease activity re- 
sponsible for the cleavage of PARP in an in vitro apoptosis 
system [lo]. CPP32 was identified as another ICE homologue 
[l I] that was recently shown to be responsible for the cleavage 
of PARP and was renamed Yamalapopain [12,13]. It has been 
suggested that CPP32A’amalapopain represents the cysteine 
protease activity originally defined by Lazbenik et al. as prICE 
in chicken cell extracts [10,12,13], although Mch2 can also 
cleave PARP [17]. The common feature among known ICE- 
family members is that cleavage by these proteases requires the 
presence of an Asp residue in the P, position, a property shared 
by cytotoxic T-cell specific granzyme B that is unique among 
serine proteases [24]. As such, the residues involved in catalysis 
and those which make up the Asp binding pocket are conserved 
in all ICE-like proteins. 
3. Non-ICE proteases in apoptosis 
ICE-like proteins are not the only proteases implicated in 
apoptosis. Many of the earlier observations illustrating the 
involvement of proteases in apoptosis came from studies using 
protease inhibitors. Several classes of protease inhibitors such 
as N-tosyl+lysyl-chloromethylketone (TLCK), N-tosyl-L- 
phenylalanyl-chloromethylketone (TPCK), tosyl-argenine 
methyl ester (TAME) and 3,4-dichloroisocoumarin (DCI) pre- 
vent apoptosis-associated DNA cleavage in various cellular 
systems [25-331 (Table 1). Some of these protease inhibitors 
might also inhibit ICE-like proteases directly or their activity 
may lie in inhibition of proteases upstream or downstream of 
ICE (see below). 
4. Substrate specificities, what is currently known 
ICE has the ability to self-process [4]. In addition, ICE can 
mediate the processing of pro-Yama [12] and pro-Nedd2 
(N.L.H., J.A. Trapani and SK., unpublished). TX/ICE,,,11 has 
thus far been the only protease shown to cleave pro-ICE, al- 
though neither TX/ICE,,,11 nor ICE,,111 cleave the ICE sub- 
strate pIL-l/I efficiently [15,16]. Similarly, prICE does not 
cleave pIL-l/I [13]. A recent study shows that ICE, TX and 
Nedd2 when overexpressed in COS cells can cleave PARP [48]. 
It is noteworthy that in in vitro experiments 50-lOO-fold higher 
concentration of purified ICE was required to cleave PARP 
than to process pro-IL-l/l [48]. In addition to cleaving PARP, 
CPP32 also cleaves sterol regulatory element-binding proteins 
SREBP-1 and SREBP-2 [49]; however, the significance of this 
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‘;ig. 2. A hypothetical model showing the role of various groups of proteases in apoptosis. The model is based on the assumption that the execution 
,)hase of apoptosis involves serial activation of different classes of proteases. Each group of proteases is represented as a black box. The rationale 
,,ehind placing the various groups in the order shown is as follows. Proteases in group 1 are probably involved in the activation of ICE-like proteases. 
rhis group involves TLCK, DC1 and TAME inhibitable proteases, which are known to be required for early apoptotic events (Table 1 and references 
‘herein). TLCK, DC1 and TAME do not inhibit all ICE-like proteases, but processing of Nedd2 is inhibited by TLCK. TLCK also inhibits PARP 
L leavage (Table 1). Group 2 proteases include ICE-like proteases capable of activating other downstream ICE-like proteases. This group may include 
iCE itself (and perhaps its closest homologues ICE,,,11 and ICEJII), which is strongly inhibited by CrmA. CTL-specific serine protease granzyme 
13 could also be classified as a member of the Group 2. Granzyme B can activate pro-Nedd2 and is inhibited by CrmA [53]. ICE is known to activate 
,ro-Nedd2 and pro-Yama/CPP32, two ICE-like proteases, probably downstream of ICE (Group 3A). Activated group 3A proteases can then cleave 
:mclear targets such as PARP. Group 2 proteases may also activate member(s) of other group(s) of ICE like proteases such as Lamp (Group 3B). 
The function of Lamp is blocked by TLCK and TPCK, but it is not clear whether these inhibitors directly interact with Lamp [52]. Group 3B proteases 
.~lso act on nuclear targets such as lamins. AC-YVAD-CMK inhibits all events associated with apoptosis. probably by inhibiting several Group 2 
nd Group 3 proteases (not shown). The cumulative action of the protease cascade culminates in events characteristic of apoptotic cell death. 
,)bservation in the context of apoptosis remains obscure. All 
hese new findings indicate that although there is some func- 
ional overlap within the ICE family of proteases, certain target 
specificities may be quite distinct between them. Interestingly, 
pro-Nedd2 can be processed by purified granzyme B (N.L.H., 
J.A.T. and SK.. unpublished), a characteristic not shared by 
‘-able 1 
“he effects of various protease inhibitors on apoptosis 
i’rotease 
nhibitor 
Target 
proteases 
Effect on apoptosis Ref. 
-AME 
‘PCK 
‘LCK 
i ICI 
“VAD-CHO. 
‘,‘VAD-CMK 
1 :rmA 
lodo-acetamide 
Serine proteases 
Chymotrypsin-like 
proteases 
Trypsin-like pro- 
teases 
Serine proteases 
ICE-like proteases 
ICE-like proteases 
and Granzyme B 
Cysteine proteases 
Inhibits TNF induced apoptosis and partly inhibits drug induced apoptosis 25, 28, 31, 33 
Inhibits drug induced, Fas induced, TNF induced and y-irradiation induced 25-27, 29931, 33 
apoptosis in a range of cell types. Inhibits proteolysis of PARP in response to cell 
treatment with drugs or y-irradiation. 
Inhibits TNF induced and drug induced apoptosis in a range of cell types. Inhibits 25, 27, 29, 31. 33 
both proteolysis of PARP and apoptosis in response to cell treatment with drugs 
or y-irradiation. 
Inhibits drug induced and Fas mediated apoptosis. 
Inhibits proteolysis of pIL-I,5 by granzyme A. 
26. 30, 43, 51 
Inhibits proteolysis of pIL-1j3 by ICE and cleavage of PARP induced in apoptotic 4, 10, 30, 42, 43 
nuclei. Inhibits Fas-mediated apoptosis. 
Inhibits proteolysis of pIL-l/I by ICE and proteolysis of PARP by prICE/CPP32/ 9, 12,40,41&l, 53 
Yama. Inhibits apoptosis induced by activation of Fas or TNF receptors, serum 
or growth factor withdrawal. Inhibits activity of granzyme B. 
Inhibits cleavage of PARP and morphological changes of apoptosis in isolated 10, 13, 27 
nuclei induced by apoptotic cell extracts and apoptosis induced by drug treatment 
and y-irradiation in a range of cell types. 
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ICE [50]. This may suggest a role for Nedd2 in cytotoxic T-cell 
mediated killing of target cells. These recent observations indi- 
cate that there is extensive interaction between the members of 
the Asp specific proteases (Fig. 1). In addition, there is some 
evidence that the processing of these zymogens to active en- 
zymes may involve proteases other than ICE-like proteins and 
granzyme B. For instance, the processing of Nedd2 is blocked 
by TLCK and TPCK, which inhibit trypsin-like and chymo- 
trypsin-like proteases, respectively (N.L.H., J.A.T. and S.K., 
unpublished). As previously mentioned, the natural substrate 
of ICE is pIL-lp, which is cleaved to generate active IL-lp. 
Curiously, granzyme A has been recently shown to process 
pIL-lp [51] and although the site at which granzyme A cleaves 
pIL-l/l differs from that of ICE, the processed IL-ID is biolog- 
ically active [51]. This further reinforces the view that there is 
functional redundancy even between different classes of pro- 
teases. 
As discussed before, a number of cellular proteins are de- 
graded during apoptosis. It is now becoming clear that some 
of these targets are cleaved by ICE-like proteases. Nuclear 
lamins are degraded by an ICE-like protease termed Lamp [52]. 
Since nuclear lamina degradation is a hallmark of the apoptotic 
nuclei, activation of Lamp might be a crucial event in the 
terminal phase of apoptosis. As yet Lamp has not been cloned 
and it remains to be seen whether it represents an already 
known member of the ICE-family. 
5. Interactions between various ICE-like proteases 
Despite substantial achievements in the past year, the role of 
proteases in apoptosis remains poorly understood. The discov- 
ery of multiple ICE-like proteases in mammalian cells has com- 
plicated the picture somewhat. Considering that most of the 
ICE-family members are expressed in all cell types, cell-specific 
function seems unlikely. Since ICE mutant mice show an appar- 
ently normal phenotype (except deficient cytokine processing 
and to some extent a defect in Fas-mediated apoptosis), ICE 
is either not required in the apoptosis pathway or there is 
functional redundancy between members of the ICE family. 
The closest structural homologues of ICE, TX/ICE,,,11 and ICE 
,,,I11 (and perhaps all other members) do not process pIL-lp 
efficiently. This means that the only undisputed function of ICE 
is the processing of pIL-la. Other ICE-like proteins, Nedd2, 
CPP32, TX, Mch2 and ICE,,,III, also induce apoptosis when 
overexpressed. Since endogenous levels of these proteins are 
usually low and not induced under apoptotic conditions, the 
physiological relevance of these experiments is not clear. The 
most convincing data on the role of these proteases in apoptosis 
has come from inhibitor studies. Both CrmA and tetrapeptide 
ICE inhibitors (e.g. AC-YVAD-CMK) strongly inhibit apopto- 
sis (Table 1). These two inhibitors probably inhibit all ICE-like 
proteases to a certain extent, therefore one cannot distinguish 
which of the proteases mediates apoptosis. YamalCPP32 has 
been claimed to be the ‘true’ homologue of Ced-3, but this may 
be partially because its known downstream target PARP, is 
cleaved in apoptotic cells [20,26]. Since Mch2 also cleaves 
PARP [ 171 and ICE, TX and Nedd2 can mediate PARP cleav- 
age when present in high enough concentrations [48], it is sim- 
plistic to assume that mammalian apoptotic pathway utilises a 
single Ced-3 homologue. Furthermore, purified CPP32 alone 
is not sufficient to provoke apoptotic changes in the cell-free 
system indicating that other cytoplasmic components may be 
required [ 131. 
6. Role of multiple proteases in apoptosis: a model 
How might several proteases fit together in the apoptosis 
pathway? Since the targets of most of the proteases are still 
unknown, and some of the proteases are yet to be identified, 
it is not possible to formulate a unified model which would 
accommodate all the findings; however, some general conclu- 
sions can be drawn. One possibility is that several proteases are 
triggered simultaneously but independently of each other in 
response to an apoptotic signal and as such no hierarchy be- 
tween various proteases would exist. As reviewed above, 
emerging data suggest that some of the ICE-members can be 
processed by others. Since some of these interactions are essen- 
tially unidirectional, e.g. ICE can process Nedd2 and prICE, 
but the reciprocal does not occur, we favour the model in which 
various proteases interact with each other in some hierarchical 
fashion (Fig. 2). Inhibitor studies also suggest that different 
classes of proteases act at different stages during the process of 
apoptosis [29,30]. Broadly speaking, the process of apoptosis 
might involve several groups of proteases including proteases 
required for the activation of ICE-like proteases (s) and ICE- 
like protease( Within the ICE-family of proteases, there may 
be two or more sub-groups. In a normal cell, various proteases 
may reside in discreet cellular compartments, and the role of 
early acting proteases might be to make it possible for the 
ICE-like proteases to interact with each other. Once the first 
group of ICE-like proteases have been activated, they will in 
turn activate the next sub-groups of proteases which act on 
various nuclear targets (Fig. 2). Cells undergoing apoptosis also 
exhibit profound cytoplasmic changes which are probably also 
mediated by selective proteolysis of certain structural proteins. 
Therefore, some of these proteases may also target certain 
proteins in the cytoplasm. 
The discovery of ICE-like proteases heralded a significant 
advancement in the understanding of the biochemical mecha- 
nism of apoptosis and it is now evident that apoptosis involves 
a cascade of proteolytic events. Further elucidation of the pro- 
teases and their substrates in the apoptotic cascade will be vital 
to understanding the execution of cell death. 
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